Pyrimidines are well known for their anticancer, antimicrobial, antioxidant and antiviral activities (1-5). Oxadiazoles are well known for their antifungal, antibacterial, anticancer and anticonvulsant activity (6-10). Indoles are also well known compounds for their antimicrobial, anticancer, antioxidant and antiviral activity (11) (12) (13) (14) (15) . In the present investigation nine pyrimidinone-oxadiazolyl indolinones were prepared. The synthesized indole derivatives of oxadiazolyl-pyrimidinones were tested for their antimicrobial and antioxidant activities. Reaction of ethyl-6-methyl-2-oxo-4-aryl-1,2,3,4-tetrahydropyrimidin-5-carboxylates (1a-i) with hydrazine hydrate yielded 6-methyl-2-oxo-4-aryl-1,2,3,4-tetrahydropyrimidin-5-carbohydrazides (2a-i). These products, on reaction with cyanogen bromide, gave 5-(5-amino-1,3,4--oxadiazol-2-yl)-6-methyl-4-aryl-3,4-dihydropyrimidin-2 (1H)-ones (3a-i). The resultant aminooxadiazolylpyrimidinones were condensed with isatin to obtain various 3-{[5-(6-methyl-4-aryl-2-oxo-1,2,3,4-tetrahydropyrimidin--5-yl)-1,3,4-oxadiazol-2-yl]-imino}-1,3-dihydro-2H-indol--2-ones (4a-i). These products were characterized by IR, 1 H NMR, mass spectra and elemental analysis. Products (4a-i) revealed promising antibacterial, antifungal and antioxidant activity.
Synthesis of 5-(5-amino-1,3,4-oxadiazol-2-yl)-6-methyl-4-aryl-2-oxo-1,2,3,4-tetrahydropyrimidin-2-(1H)-ones (3a-i)
To 0.01 mol of 2a in absolute ethanol (25 mL), an aqueous solution of sodium bicarbonate (2 g in 5 mL water) was added and stirred for a few minutes at room temperature. Cyanogen bromide (0.01 mol, 1.05 g) was then added and stirring was continued for 36 h. Concentration of the reaction mixture to ¼ of its volume left a residue, which was poured over crushed ice (10) . The solid separated was filtered, dried and crystallized from ethanol when product 3a was obtained. The procedure was repeated for other compounds of the series. The analytical data are given in Table I . Compound 3a (0.01 mol) and isatin (0.01 mol) were refluxed in methanol in the presence of a catalytic amount of glacial acetic acid for 30 min and cooled. The solid separated was filtered off and crystallized (17) . The other derivatives were prepared in the same manner. The analytical and spectral data are given in Tables I and II .
Antibacterial and antifungal studies
Antibacterial screening of the synthesized compounds 4a-i was performed by the agar disc diffusion method (17) . The organisms used were Staphylococcus aureus (NCIM 2079), Bacillus subtilis (NCIM 2063), Escherichia coli (NCIM 2118) and Pseudomonas aeruginosa (NCIM 2036). The minimum inhibitory concentration (MIC) was determined by the serial dilution technique using dimethyl sulphoxide (DMSO) as solvent. DMSO was used as a negative control. Ciprofloxacin was used as the standard in all antibacterial screening studies.
The antifungal screening of compounds 4a-i was done by the agar disc diffusion method (18) . Aspergillus niger (NCIM 596) and Candida albicans (NCIM 3102) were used as test organisms. Dimethyl sulphoxide was used as a solvent and fluconazole was used as a standard. A control experiment with dimethyl sulphoxide alone was done for antifungal studies.
The results of antimicrobial studies are presented in Table III .
Antioxidant studies
Free radical scavenging activity of the test compounds 4a-i was studied by the diphenyl picryl hydrazyl (DPPH) assay method (19) . Drug stock solution (1 mg mL -1 ) was diluted to final concentrations of 2, 4, 6, 8 and 10 mg mL -1 in methanol. DPPH methanol solution (1 mL, 0.3 mmol) was added to 2.5 mL of drug solutions of different concentra- tions and allowed to react at room temperature. After 30 min the absorbance values were measured at 518 nm and converted into the percentage antioxidant activity. Methanol was used as the solvent and ascorbic acid as the standard. The trials were done in triplicate. The inhibitory concentration (IC 50 ) value, representing the concentration required to exhibit 50% antioxidant activity, was extrapolated from the graph plotted with percentage antioxidant activity (AA %) on the y axis and concentration on the x axis ( Fig. 1) . Results are presented in Table IV . (Table II) (Table II) showed bands at 3478, 2927, 1734, 1608, 1571, 1347 and 1222 cm -1 , respectively, for N-H, C-H aliphatic, C=O aromatic, C=C aromatic, C=N and C-N. 1 H NMR spectra (Table II) showed a singlet at d 9. Elemental analysis data together with spectral data revealed that compounds 4a-i were successfully synthesized.
Antibacterial, antifungal and antioxidant activities of all the newly prepared compounds are shown in Tables III and IV. The antibacterial activity of compounds 4a, 4d and 4i is considerable and is equivalent to that of the reference drug ciprofloxacin. Compound 4a with unsubstituted phenyl subtituent showed the highest degree of activity against Pseudomonas aeruginosa and Bacillus subtilis, 4d with trimethoxy phenyl subtituent against Staphylococcus aureus and Bacillus subtilis, whereas 4i possess p-amino dimethyl phenyl group showed activity against Bacillus subtilis and Pseudomonas aeruginosa.
The antifungal studies showed that 4i possesses superior activity against Aspergillus niger than the other compounds and the reference drug fluconazole. Compounds 4a and 4d also possess comparable activity against Aspergillus niger when compared to the standard. Both 4d and 4i showed equivalent activity with reference drug against Candida albicans.
The above studies revealed that compounds 4a, 4d and 4i showed comparable antimicrobial activity against the tested bacteria and fungi. The unsubstituted phenyl, trimethoxy phenyl and p-amino dimethyl phenyl derivatives of the title compound were found to be the lead antimicrobial agents.
The antioxidant studies revealed that compound 4e with isopropyl substitution showed the best free radical scavenging activity, comporable to that of ascorbic acid, followed by 4d and 4h which showed comparable activity. 
